Business Description
K Pharma Inc
ISIN : JP3280900006
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.97 | |||||
Piotroski F-Score | 7/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 89.97 | |||||
9-Day RSI | 79.37 | |||||
14-Day RSI | 72.11 | |||||
6-1 Month Momentum % | -4.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 42.73 | |||||
Quick Ratio | 42.6 | |||||
Cash Ratio | 42.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | 44.46 | |||||
ROE % | -20.41 | |||||
ROA % | -18.6 | |||||
ROIC % | -777.34 | |||||
ROC (Joel Greenblatt) % | -129607.29 | |||||
ROCE % | -21.3 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.98 | |||||
PB Ratio | 2.87 | |||||
Price-to-Tangible-Book | 2.86 | |||||
Price-to-Free-Cash-Flow | 17.93 | |||||
Price-to-Operating-Cash-Flow | 17.56 | |||||
EV-to-EBIT | -10.2 | |||||
EV-to-EBITDA | -10.2 | |||||
EV-to-Revenue | 5.27 | |||||
EV-to-FCF | 9.58 | |||||
Price-to-Net-Current-Asset-Value | 2.86 | |||||
Price-to-Net-Cash | 2.9 | |||||
Earnings Yield (Greenblatt) % | -9.79 | |||||
FCF Yield % | 5.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
K Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 1,000 | ||
EPS (TTM) (円) | -45.093 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 72.11 | ||
14-Day ATR (円) | 24.168994 | ||
20-Day SMA (円) | 642.1 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (円) | 531 - 980 | ||
Shares Outstanding (Mil) | 11.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
K Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
K Pharma Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
K Pharma Inc Frequently Asked Questions
What is K Pharma Inc(TSE:4896)'s stock price today?
When is next earnings date of K Pharma Inc(TSE:4896)?
Does K Pharma Inc(TSE:4896) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |